Chemotherapy is beneficial for elderly patients with advanced non-small-cell lung cancer: Analysis of patients aged 70-74, 75-79, and 80 or older in Japan

Clinical Lung Cancer

Volumn 13, Issue 6, 2012, Pages 442-447

  Kawaguchi, Tomoya ^a   Tamiya, Akihiro ^a   Tamura, Atsuhisa ^b   Arao, Masamichi ^c   Saito, Ryusei ^d   Matsumura, Akihide ^a   Ou, Sai Hong I ^e   Tamura, Taro ^c  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^b TOKYO NATIONAL HOSPITAL   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d Shibukawa Medical Center   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Advanced stage; Chemotherapy; Database; Elderly; Epidemiology

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; GEMCITABINE; NAVELBINE; PLATINUM DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR;

ADVANCED CANCER; AGED; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DATA BASE; FEMALE; GERIATRIC PATIENT; HAZARD RATIO; HUMAN; JAPANESE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; REVIEW; SMOKING; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

EID: 84867503374     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2012.03.010     Document Type: Article

References (24)

1. P. Jha Avoidable global cancer deaths and total deaths from smoking Nat Rev Cancer 9 2009 655 664
2. T.K. Owonikoko, C.C. Ragin, C.P. Belani Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database J Clin Oncol 25 2007 5570 5577
3. T. Kawaguchi, M. Takada, A. Kubo Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC J Thorac Oncol 5 2010 620 630
4. C. Gridelli, C. Langer, P. Maione Lung cancer in the elderly J Clin Oncol 25 2007 1898 1907
5. C. Gridelli, A. Rossi, P. Maione Challenges treating older non-small cell lung cancer patients Ann Oncol 19 2008 109 113
6. The elderly Lung Cancer Vinorelbine Italian Study Group Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer J Natl Cancer Inst 91 1999 66 72
7. G. Frasci, V. Lorusso, N. Panza Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer J Clin Oncol 18 2000 2529 2536
8. C. Gridelli, F. Perrone, C. Gallo Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial J Natl Cancer Inst 95 2003 362 372
9. S. Kudoh, K. Takeda, K. Nakagawa Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG 9904) J Clin Oncol 24 2006 3657 3663
10. E.A. Quoix, J. Oster, V. Westeel Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC) J Clin Oncol 28 suppl:18 2010 Abstract 2
11. P.J. Hesketh, R.C. Lilenbaum, K. Chansky Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6 J Thorac Oncol 2 2007 494 498
12. T. Kawaguchi, A. Matsumura, S. Fukai Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases J Thorac Oncol 5 2010 1001 1010
13. T. Kawaguchi, M. Takada, A. Kubo Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan J Thorac Oncol 5 2010 1011 1017
14. W.D. Travis, T.V. Colby, B. Corrin Histological typing of lung and pleural tumors World Health Organization International Histological Classification of Tumors 3rd ed. 1999 Springer Berlin
15. I.D. Fleming, J.S. Cooper, D.E. Henson American Joint Committee: AJCC Cancer Staging Manual 5th ed. 1997 Lippincott-Raven Philadelphia
16. F.L. Greene, D.L. Page, I.D. Fleming American Joint Committee: AJCC Cancer Staging Manual 6th ed. 2002 Lippincott-Raven Philadelphia
17. W.M. Alberts American College of Chest Physicians Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition) Chest 132 3 suppl 2007 1S 19S
18. J.H. Schiller, D. Harrington, C.P. Belani Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 2002 92 98
19. Y.M. Chen, R.P. Perng, M.C. Chen A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older Lung Cancer 40 2003 221 226
20. A.J. Davidoff, M. Tang, B. Seal Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer J Clin Oncol 28 2010 2191 2197
21. A. Tamiya, T. Naito, A. Ono Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more Lung Cancer 71 2011 173 177
22. The world health report 2006: working together for health 2006 World Health Organization Geneva
23. S. Sun, J.H. Schiller, A.F. Gazdar Lung cancer in never smokers - a different disease Nature 7 2007 778 790
24. A. Inoue, K. Kobayashi, K. Usui First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy J Clin Oncol 27 2009 1394 1400